JNCE

Jounce Therapeutics, Inc. Common Stock
JNCE

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

JNCE was delisted on the 3rd of May, 2023.

Back to rankings

58 hedge funds and large institutions have $270M invested in Jounce Therapeutics, Inc. Common Stock in 2017 Q1 according to their latest regulatory filings, with 58 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
58
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$82.4M
2
+$34.8M
3
+$22.5M
4
PI
Pharmstandard International
Luxembourg
+$14.6M
5
OFM
Omega Fund Management
Massachusetts
+$12.7M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$82.4M
2
$34.8M
3
$22.5M
4
$14.6M
5
$12.7M
6
$11M
7
$10.3M
8
$9.56M
9
$6.6M
10
$6.46M
11
$6.31M
12
$5.79M
13
$5.68M
14
$3.75M
15
$3.55M
16
$3.02M
17
$2.86M
18
$2.76M
19
$2.64M
20
$2.51M
21
$2.35M
22
$2.2M
23
$2.2M
24
$2.01M
25
$1.57M
1
2 3